Biotech Distilled

Substack ↗ Subscribe

Subscribe Substack ↗ About

Research Areas Modalities Phases Targets Track record Movers The Lead Compound

Home › Targets › RORA

RORA (1 companies · 2 programs)

Companies with an active program directed at RORA.

Ocugen, Inc. OCGN

OCU410ST — Stargardt Disease Phase 3
OCU410 — Geographic Atrophy Phase 2

Track record About Feedback Report a bug Substack ↗

This website is an encyclopedia of clinical-stage biotech companies, refreshed weekly. For informational and educational use only — not investment advice. Always verify against primary sources before making decisions.